ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:September 7, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:September 7, 2012Completed
Condition(s):Ocular Hypertension; Open Angle GlaucomaLast Updated:February 2, 2021Completed
Condition(s):Elevated Intraocular PressureLast Updated:May 25, 2022Active, not recruiting
Condition(s):Primary Open-angle Glaucoma; Ocular HypertensionLast Updated:May 18, 2021Unknown status
Condition(s):Ocular Hypertension (OHT); Mild Open Angle-glaucoma (OAG)Last Updated:June 3, 2013Completed
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:February 2, 2021Completed
Condition(s):Open-angle Glaucoma; Ocular HypertensionLast Updated:December 17, 2012Completed
Condition(s):Ocular Hypertension; Primary Open Angle GlaucomaLast Updated:May 25, 2023Completed
Condition(s):Glaucoma; Ocular HypertensionLast Updated:December 14, 2016Completed
Condition(s):Open-angle Glaucoma; Ocular HypertensionLast Updated:February 14, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.